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Abstracts / Urological Science 26 (2015) 288e293 289Materials and Methods: Cellular proteins from four pairs of surgically
resected primary bladder cancer tumor and adjacent nontumorous tissue
were extracted for two batches of isobaric tags for relative and absolute
quantitation (iTRAQ) experiments. The DAVID (database for annotation,
visualization and integrated discovery) is used for analysis of dysregulated
proteins. ELISA were employed for validation of candidate tumor markers
in tissues and the age-matched urine specimens from bladder cancer pa-
tients and hernia patients as control were compared.
Results: The iTRAQ experiments identiﬁed a total of 3220 proteins. Seven
differentially expressed proteins were selected as potential bladder cancer
biomarkers for further veriﬁcation. Immunohistochemical analyses
showed signiﬁcantly elevated levels of three proteins- SLC3A2, STMN1, and
TAGLN2- in tumor cells compared with noncancerous bladder epithelial
cells, and suggested that TAGLN2 could be a useful tumor tissue marker for
diagnosis (AUC¼ 0.999). The DAVID analysis revealed three top-ranking
biological processes as involved in extracellular matrix organization,
extracellular structure organization, and oxidation-reduction. ELISA
revealed signiﬁcantly increased urinary levels of both STMN1 and TAGLN2
in bladder cancer subgroups compared with control groups. Urinary
TAGLN2 in bladder cancer samples showed the largest fold change (7.13-
fold), with an AUC value of 0.70 (p < 0.001, n¼ 205).
Conclusion: Our study discovered that TAGLN2 showed the most signiﬁ-
cant over expression in bladder cancer tissues and urine specimens, and
thus represents a potential biomarker for noninvasive screening for
bladder cancer.
PD1-4:
ANALYSIS OF PROSTATE CANCER FOCI IN PATIENTS WITH TRANSRECTAL
10-CORE SYSTEMIC RANDOM BIOPSYdCAN WE PREDICT
PATHOLOGICAL STAGE OF PROSTATE CANCER THROUGH TRUS BIOPSY?
Kuan-Yu Wu, Yuh-Shyan Tsai, Wen-Horng Yang, Tzong-Shin
Tzai. Department of Urology, College of Medicine and Hospital, National
Cheng Kung University, Tainan, Taiwan
Purpose: The aim of this study is evaluating the detection site of prostate
cancer foci in patients receiving transrectal ultrasound(TRUS) guided 10-
core systemic random biopsy and comparing the relationship between
digital rectal examination and prostatic biopsy. The study ultimately aims
to predict pathological staging of prostate cancer by TRUS-biopsy.
Materials and Methods: Between September 2005 and June 2014, 1314
men received TRUS-guided biopsy were included in this study. Indications
for TRUS guided prostate biopsy were: abnormal digital rectal examination
and/or a serum PSA over 4.0 ng/ml. 701 patients were excluded due to less
than 10 cores or received target biopsy and 68 patients were excluded due
to different machine. Finally, 545 patients underwent at least 10-core
random biopsy protocol by TRUS and 46 of those patients treated with
radical retropubic prostatectomy.
Results: Of the 545 patients, one hundred and ﬁfty-two (27.9%) were
positive for prostate cancer, including 64 of 370 (16.2 %) men with normal
DRE and 88 of 175 (50.3 %) with abnormal DRE. Patients with normal DRE
exhibited younger age (67.9 vs. 71.0 yrs, p¼ 0.007), lower serum PSA(15.7
vs. 25.6 ng/ml, p¼ 0.0032), lower PSA density(0.41 vs. 0.71, p¼ 0.0016),
less positive cores(p¼ 0.022), and less Gleason score(p¼ 0.0006) than
those with abnormal DRE.
46 of those patients treated with radical retropubic prostatectomy,
including 17 men with normal DRE and 29 with abnormal DRE. The
pathological ﬁnding revealed higher number of positive biopsy cores in
advanced staging whether digital ﬁnding was positive or not. For eval-
uating the association of the detection site of prostate cancer foci and
pathological staging, we deﬁned low, intermittent, and high risk group
according to number of positive cores in different locations (lateral,
parasagittal, and apical area). We identiﬁed low risk group with no
positive core. Intermittent risk group means one positive core or 2
positive cores ipsilateral (2S). High risk group means 2 positive cores
contralateral (2C) or number of positive cores more than 3. Otherwise,
we also reclassiﬁed pathological staging into 3 subgroups: pT2a and
pT2b, pT2c, and pT3a at least. The pathological ﬁnding of patient with
low risk group will below pT2c and high-risk group will above pT3.
(p¼ 0.031 in lateral sites, p¼ 0.007 in parasagittal sites, and p¼ 0.023 in
apical sites).Conclusions: In our study, patient with normal digital rectal examination
and PSA elevation received TURS-biopsy has 16% malignancy change. Be-
sides, patients with abnormal digital rectal examination received TURS-
biopsy has 50% malignancy change. Patients with normal DRE exhibited
younger age, lower serum PSA, lower PSA density, less positive cores, and
less Gleason score than those with abnormal DRE. The cancer foci detected
by biopsies of the prostate are equally distributed even subgroup analysis
depending on location of positive cores or prostate size. Prediction of
pathological stage in prostate cancer through TRUS 10-core random biopsy
is available in this study.
PD1-5:
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Purpose:MicroRNAs (miRNAs) represent a class of small non-coding RNAs
regulating gene expression by inducing the degradation of RNA or inter-
fering with translation. Aberrant miRNA expression has been described in
several types of cancer in humans. By our pre-set miR array data, we iden-
tiﬁed miR-145 as the most signiﬁcant tumor suppressor mir in urothelial
carcinoma (UC). However, the expression of miR-145 in UC of the upper
urinary tract (UTUC) has not been investigated. This study is conducted to
evaluate the outcome predictive value of miR-145 expression in UTUC.
Materials and Methods: Using a miRNA array (Applied Biosystems) that
included 667 human miRNAs and mammalian RNU6B, we compare the
differentially expressed miRNAs between BFTC909 cell line and paired
UTUC samples. The miR-145 expression levels from 65 UTUC tissues and
the paired adjacent noncancerous tissues were investigated by Real-Time
Reverse Transcriptase PCR assay. In addition, the functional consequences
of miR145 transfection in BFTC909 cells were studied in vitro by MTT,
wound healing, cell migration, cell invasion assays.
Results: In 65 paired tissues, we found that mir-145 expression was
signiﬁcantly decreased in UTUC tissues than in paired adjacent noncan-
cerous tissues. Decreased mir-145 expression was associated with worse
recurrence-free and cancer-speciﬁc survival. In cell line experiments, we
demonstrated that mir145 can inhibit cell proliferation, migration and
invasion in BFTC909 cell line after transfection of miR145 mimics.
Conclusion: Our ﬁndings imply that decreased miR-145 expression is a
potential biomarker to predict clinical outcome of UTUC patients. Further
study is necessary to identify the molecular mechanisms of miR-145
involved in the cancerous processes of UTUC.
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BY INHIBITING SNAIL SIGNALING, OSTHOLE SUPPRESSES THE EMT-
MEDIATED METASTATIC ABILITY IN PROSTATE CANCER
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2Department of Education and Research, Wan Fang Hospital, Taipei
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Purpose: To evaluate the anti-metastatic potential of osthole in prostate
cancer cells and xenograft animal model.
Materials andMethods: The PC3 and DU145 human adrogen independent
prostate cancer (AIPC) cell lines were obtained from American Type Cul-
ture Collection for cell assay. PC-3M, a highly metastatic subline derived
from the hepatic metastasis of PC-3 in nude mice, was used for xenograft
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assays for tumor growth and metastasis in an orthotopic graft model.
Western blot analysis, reverse-transcriptase polymerase chain reaction
(RT-PCR) and Chromatin immunoprecipitation (ChIP) analysis were used
for check-up.
Results: Osthole suppress the migratory/invasive abilities of prostate
cancer cells in wound-closure and transwell invasion assay and metastatic
potential in prostate cancer xenograft model. Osthole suppresses the snail-
induced EMT in prostate cancer cells and animal model. Mechanistic in-
vestigations revealed a signal cascade, namely, osthole inhibiting TGF-
b/Akt/MAPKs/snail, in which osthole reduced Snail-DNA-binging
activity and upregulated E-cadherin expression and subsequently blocked
EMT progression.
Conclusions: We suggest that osthole inhibits metastasis via transcrip-
tional regulation of E-cad by respectively altering Akt/MAPK/Snail path-
ways, which was initiated by inhibition of TGF-b productin. These results
may warrant clinical trials of osthole in AIPC.Podium-2
other
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Purpose: The purpose of the present study was to determine the platelet
rich plasma (PRP) action target that mediates its effect on erectile function
(EF) recovery in the bilateral cavernous nerve crush (BCNC) injury rat
model.
Materials and Methods: 52 rats were randomly divided into two equal
groups: intracavernosal injection (IC) of saline after BCNC (group 1)
and IC injection of PRP after BCNC (group 2). Five animals in each
group were euthanized at 3 and 7 day (d) post-injection, and the tis-
sues were harvested to conduct transmission electron microscopy
(TEM) and histological assays in the penis, cavernous nerve (CN), and
major pelvic ganglion (MPG). Eight animals in each group were used to
determine the recovery of EF at 14 and 28 d post-injury, after which
the penis, CN, and MPG tissues were harvested to conduct TEM and
histological assays.
Results: Intracavernosal injections of PRP increased all erectile function
parameters at 28 d (p<0.05) but not 14 d (p¼ 0.55) post-injury. PRP in-
jections simultaneously prevented the loss of neural nitric oxide synthase
(nNOS)-positive neurons (p<0.05) and nerve ﬁbers (p<0.05) in the MPG
and CN compared with group 1, respectively, which accelerated the
regeneration of myelinated axons of the CN, reduced apoptosis, and
enhanced the proliferation of the corporal smooth muscle cells at an
earlier stage.
Conclusions: The results of this study suggest that the application of PRP
for erectile dysfunction caused by BCNC-related axonotmesis was beneﬁ-
cial to restore EF via both neuroprotective and tissue-protective effects.
PD2-2:
PATIENT CHARACTERISTICS FOR DIFFERENT THERAPEUTIC STRATEGIES
IN THE MANAGEMENT OF KETAMINE CYSTITIS
Yu-Khun Lee, Hann-Chorng Kuo. Department of Urology, Hualien Tzu Chi
Hospital, Huelien, Taiwan
Purpose: This study analyzed the ketamine cystutus(KC) patient charac-
teristics between who received conservative management and augmen-
tation enterocystoplasty (AE).Materials and Methods: A total of 53 patients with chronic ketamine
abuse and lower urinary tract symptoms visiting urological clinic of a
tertiary teaching hospital in Eastern Taiwan were included in this study.
All of the patients have been initially treated conservatively but failed.
They were admitted for detailed urological examinations including
cystoscopic hydrodistention and urinary tract image study. Patients
were classiﬁed according to their maximal bladder capacity (MBC). The
patients with extremely small MBC (<100ml) with or without upper
urinary tract damage and very small MBC with upper urinary tract
damage were recommended to receive AE. The other patients were
recommended to receive symptomatic treatment. The patient charac-
teristics and bladder condition are compared between patients with AE
and conservative treatment. Treatment outcome was also assessed in
these two groups.
Results: Among the participants, 28 patients underwent AE and 25 were
managed with conservative treatment. The only signiﬁcant difference
between groups was more patients with urgency urinary incontinence
(UUI) underwent AE. Patients underwent AE had signiﬁcantly smaller
MBC, thicker bladder wall, and higher incidence of vesicoureteral reﬂux.
Signiﬁcantly more patients underwent AE reported a good outcome.
Most of the patients received conservative treatment only had a fair
result.
Conclusions: KC patients who already developed a contracted bladder
with extremely small bladder capacity (<100ml) or very small capacity
(100-300ml) with irreversible urinary tract change, partial cystectomy and
AE seems necessary for early restoration of a normal lower urinary tract
function. The treatment outcome of AE is better than patients with con-
servative treatment.
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Purpose: Persistent stress urinary incontinence (SUI) occurs approximate
10% ~30% patients after radical prostatectomy (RP). The aim of the study
was to evaluate the effectiveness and safety of the pelvic ﬂoor muscle
training (PFMT) and retrourethral transobturator sling for the treatment of
male SUI.
Materials andMethods: This study documents a single-center prospective
evaluation of the outcome of 26 patients with SUI following RP in whom
received PFMT and male sling between 2012 Feb and 2015 Feb. All patients
were comprehensively evaluated pre-training, post-training, preopera-
tively and after 6 months regarding daily pad use, ULCA male incontinence
questionnaires, patients’ satisfaction, post-voiding residual urine and
complications.
Results: The mean patients’ age was 69.3 ± 7.7 years (range 63-82) and
the mean pad use was 3.7 ± 2.6 per day (range 1-7). Baseline urody-
namic study showed mean Qmax was 12.8 ± 8.0mL, voided volume was
161± 126mL, PVR was 19 ± 30mL, ALPP was 48.9± 34.2 cmH2O and
CLPP was 68.6 ± 25.1cmH2O. After 12 courses of pelvic ﬂoor retraining in
3 months, The use of daily pad was signiﬁcantly decreased from 3.7 ± 2.6
to 2.4 ± 1.5, p¼ 0.02. However the UCLA score was not signiﬁcantly
changed (82.8± 75.1 to 70.2± 34, p¼ 0.25). The patients’ satisfactory
rate was 40%. Of them, 12 patients received transobturator male sling
after failed conservative treatment. Retrograde urethral pressure proﬁle
was measured with 60cmH2O leakage point pressure setting after
placing sling. Compared with preoperative status, the use of daily pad
was signiﬁcantly decreased from 4.7 ± 2.3 to 0.5 ± 1.0, p<0.001. The
UCLA score was signiﬁcantly increased from 62.0 ± 40.3 to 248± 177,
p<0.001. The overall patients’ satisfactory rate was 91.7%. One patient
suffered from temporary acute urinary retention and one patient had
perineal skin erosion.
Conclusions: Conservative treatment has limited effects for male SUI after
RP. Mail sling is an effective and safe procedure for treatment of male SUI
during the short-term followup.
